Heart Failure
Showing NaN - NaN of 118
Heart Failure Trial in United States (Digital Engagement, Direct Engagement)
Completed
- Heart Failure
- Digital Engagement
- Direct Engagement
-
Birmingham, Alabama
- +153 more
Jan 22, 2021
Left Ventricular Assist Devices Using the CardioMEMS™
Completed
- Heart Failure
- Hemodynamic management using CardioMEMS
-
La Jolla, California
- +22 more
Jan 7, 2021
Metabolic Parameters 3 Months, 9 Months, and 2 Years After
Completed
- Obesity
- +3 more
- Bariatric surgery
-
Houston, TexasUniversity of Texas, Health Sciences Center Houston
Nov 3, 2020
Heart Failure Trial in United States (GUIDED-HF, Standard of Care)
Completed
- Heart Failure
- GUIDED-HF
- Standard of Care
-
Atlanta, Georgia
- +14 more
Apr 17, 2020
Heart Failure Trial in United States (Mesenchymal Precursor Cells (MPCs), standard-of-care treatment with mock mapping and
Completed
- Heart Failure
- Mesenchymal Precursor Cells (MPCs)
- standard-of-care treatment with mock mapping and injection procedures.
-
Gilbert, Arizona
- +5 more
Mar 9, 2020
VITROS Immunodiagnostic Products NT-proBNP II
Completed
- Heart Failure
- VITROS Immunodiagnostic Products
-
Montgomery, Alabama
- +24 more
Mar 5, 2020
Heart Failure, Cancer Treatment Induced Left Ventricular Dysfunction Trial in Houston (Echocardiograms, Electrocardiogram,
Completed
- Heart Failure
- Cancer Treatment Induced Left Ventricular Dysfunction
- Echocardiograms
- +3 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jan 27, 2020
Heart Failure Trial in Worldwide (Attain Stability Quad Left Ventricular Pacing Lead)
Completed
- Heart Failure
- Attain Stability Quad Left Ventricular Pacing Lead
-
Phoenix, Arizona
- +49 more
Dec 19, 2019
Heart Failure Trial in Canada, United States (DuraHeart Left Ventricular Assist System (LVAS))
Terminated
- Heart Failure
- DuraHeart Left Ventricular Assist System (LVAS)
-
Birmingham, Alabama
- +25 more
Dec 11, 2019
Heart Failure, Respiratory Insufficiency, Stroke Acute Trial in Worldwide (Rivaroxaban, 10 mg, Rivaroxaban, 7.5 mg, Placebo)
Completed
- Heart Failure
- +4 more
- Rivaroxaban, 10 mg
- +2 more
-
Birmingham, Alabama
- +616 more
Nov 5, 2019
Heart Failure Trial in United States (Chronicle Implantable Hemodynamic Monitor, Standard of Care)
Completed
- Heart Failure
- Chronicle Implantable Hemodynamic Monitor
- Standard of Care
-
Birmingham, Alabama
- +27 more
Aug 13, 2019
Model 4296 Left Ventricular (LV) Lead Chronic Performance Study
Completed
- Heart Failure
-
Birmingham, Alabama
- +98 more
Jul 19, 2019
Heart Failure Trial in Worldwide (Iobenguane I -123 Injection, Implantable Cardioverter Defibrillator, Thyroid blocking)
Terminated
- Heart Failure
- Iobenguane I -123 Injection
- +2 more
-
Birmingham, Alabama
- +93 more
Apr 26, 2019
Heart Failure Trial in Houston, San Antonio (Usual Care, Exercise Training, Dietary Counseling)
Unknown status
- Heart Failure
- Usual Care
- +2 more
-
Houston, Texas
- +1 more
May 16, 2019
Heart Failure, Coronary Artery Disease Trial in Worldwide (Rivaroxaban, Placebo, Standard of care for heart failure and coronary
Completed
- Heart Failure
- Coronary Artery Disease
- Rivaroxaban
- +2 more
-
Alexander City, Alabama
- +577 more
Apr 18, 2019
Longitudinal Surveillance Registry (LSR) of ACUITY Spiral
Terminated
- Heart Failure
- ACUITY Spiral Left Ventricular Lead
-
Birmingham, Alabama
- +96 more
Jan 31, 2019
Heart Failure Trial in Worldwide (Neladenoson bialanate (BAY1067197), Placebo)
Completed
- Heart Failure
- Neladenoson bialanate (BAY1067197)
- Placebo
-
Naples, Florida
- +74 more
Apr 19, 2019
Quadripolar Pacing Post Approval Study
Completed
- Heart Failure
- CRT-D System
-
Birmingham, Alabama
- +70 more
Apr 12, 2019
Heart Failure, Cardiac Arrhythmia Trial in Worldwide (CRT implantation, MediGuide, EP)
Terminated
- Heart Failure
- Cardiac Arrhythmia
- CRT implantation
- +2 more
-
Phoenix, Arizona
- +15 more
Jan 31, 2019